SG11201805440RA - Diagnosis of unstable angina - Google Patents
Diagnosis of unstable anginaInfo
- Publication number
- SG11201805440RA SG11201805440RA SG11201805440RA SG11201805440RA SG11201805440RA SG 11201805440R A SG11201805440R A SG 11201805440RA SG 11201805440R A SG11201805440R A SG 11201805440RA SG 11201805440R A SG11201805440R A SG 11201805440RA SG 11201805440R A SG11201805440R A SG 11201805440RA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- unstable angina
- diagnosis
- christchurch
- english
- Prior art date
Links
- 206010002388 Angina unstable Diseases 0.000 title abstract 4
- 208000007814 Unstable Angina Diseases 0.000 title abstract 4
- 201000004332 intermediate coronary syndrome Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562271928P | 2015-12-28 | 2015-12-28 | |
| PCT/NZ2016/050207 WO2017116239A1 (en) | 2015-12-28 | 2016-12-23 | Diagnosis of unstable angina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805440RA true SG11201805440RA (en) | 2018-07-30 |
Family
ID=59225200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805440RA SG11201805440RA (en) | 2015-12-28 | 2016-12-23 | Diagnosis of unstable angina |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190011463A1 (zh) |
| EP (1) | EP3397959A4 (zh) |
| JP (1) | JP2019502933A (zh) |
| CN (1) | CN108780079A (zh) |
| AU (1) | AU2016382408A1 (zh) |
| CA (1) | CA3009737A1 (zh) |
| SG (1) | SG11201805440RA (zh) |
| WO (1) | WO2017116239A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021002445A2 (pt) | 2018-08-10 | 2021-05-04 | F. Hoffmann-La Roche Ag | métodos para prever o risco de acidente vascular cerebral, para aprimorar a precisão da previsão de uma pontuação de risco clínico, para avaliar a eficácia de uma terapia, para identificar um paciente e para monitorar um paciente, usos e kit |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005052593A1 (en) * | 2003-10-29 | 2005-06-09 | The University Of Leicester | Detection |
| CN101611318B (zh) * | 2006-09-07 | 2015-03-04 | 奥塔哥创新有限公司 | 生物标记物 |
-
2016
- 2016-12-23 WO PCT/NZ2016/050207 patent/WO2017116239A1/en active Application Filing
- 2016-12-23 EP EP16882174.2A patent/EP3397959A4/en not_active Withdrawn
- 2016-12-23 SG SG11201805440RA patent/SG11201805440RA/en unknown
- 2016-12-23 US US16/065,981 patent/US20190011463A1/en not_active Abandoned
- 2016-12-23 CN CN201680082678.6A patent/CN108780079A/zh active Pending
- 2016-12-23 JP JP2018552627A patent/JP2019502933A/ja active Pending
- 2016-12-23 CA CA3009737A patent/CA3009737A1/en not_active Abandoned
- 2016-12-23 AU AU2016382408A patent/AU2016382408A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016382408A1 (en) | 2018-07-19 |
| US20190011463A1 (en) | 2019-01-10 |
| EP3397959A4 (en) | 2019-04-24 |
| EP3397959A1 (en) | 2018-11-07 |
| CA3009737A1 (en) | 2017-07-06 |
| JP2019502933A (ja) | 2019-01-31 |
| WO2017116239A1 (en) | 2017-07-06 |
| CN108780079A (zh) | 2018-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201408385TA (en) | Methods of detecting diseases or conditions | |
| SG11201807002TA (en) | Intention signaling for an autonomous vehicle | |
| SG11201811709WA (en) | Compounds, compositions, and methods for the treatment of disease | |
| SG11201811740WA (en) | Systems and methods for identifying risky driving behavior | |
| SG11201906373VA (en) | Chemical compounds as inhibitors of interleukin-1 activity | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201805906WA (en) | Diagnostic and prognostic methods for cardiovascular diseases and events | |
| SG11201810694WA (en) | Use of biomarkers in determining susceptibility to disease treatment | |
| SG11201805950UA (en) | Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them | |
| SG11201806267QA (en) | Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose | |
| SG11201408383SA (en) | Methods of detecting diseases or conditions using circulating diseased cells | |
| SG11201908743SA (en) | Methods and compositions for modulation of immune cells | |
| SG11201906959RA (en) | Aryl hydrocarbon receptor (ahr) modulator compounds | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201806284TA (en) | Low pressure separator having an internal divider and uses therefor | |
| SG11201909003YA (en) | Integrated vascular access device and anchor pad | |
| SG11201408434QA (en) | Targeted rna-seq methods and materials for the diagnosis of prostate cancer | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201806432PA (en) | Methods for assessing risk of developing colorectal cancer | |
| SG11201910195WA (en) | Methods for trapping and barcoding discrete biological units in hydrogel | |
| SG11201907364WA (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer | |
| SG11201810786RA (en) | [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation | |
| SG11201903202VA (en) | Osmotic membrane |